These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 6196802

  • 1. Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers.
    Nybäck H, Berggren BM, Hindmarsh T, Sedvall G, Wiesel FA.
    Psychiatry Res; 1983 Aug; 9(4):301-8. PubMed ID: 6196802
    [Abstract] [Full Text] [Related]

  • 2. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
    Hjärpe J, Söderman E, Andreou D, Sedvall GC, Agartz I, Jönsson EG.
    Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
    [Abstract] [Full Text] [Related]

  • 3. Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.
    Hsiao JK, Colison J, Bartko JJ, Doran AR, Konicki PE, Potter WZ, Pickar D.
    Arch Gen Psychiatry; 1993 Aug; 50(8):606-14. PubMed ID: 7688209
    [Abstract] [Full Text] [Related]

  • 4. Cerebrospinal fluid monoamine metabolite concentrations as intermediate phenotypes between glutamate-related genes and psychosis.
    Andreou D, Söderman E, Axelsson T, Sedvall GC, Terenius L, Agartz I, Jönsson EG.
    Psychiatry Res; 2015 Sep 30; 229(1-2):497-504. PubMed ID: 26142836
    [Abstract] [Full Text] [Related]

  • 5. CSF monoamine metabolites in chronic schizophrenic patients who attempt suicide.
    Roy A, Ninan P, Mazonson A, Pickar D, Van Kammen D, Linnoila M, Paul SM.
    Psychol Med; 1985 May 30; 15(2):335-40. PubMed ID: 2410941
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF.
    Nikisch G, Baumann P, Wiedemann G, Kiessling B, Weisser H, Hertel A, Yoshitake T, Kehr J, Mathé AA.
    J Clin Psychopharmacol; 2010 Oct 30; 30(5):496-503. PubMed ID: 20814316
    [Abstract] [Full Text] [Related]

  • 8. Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Their relationships in schizophrenic patients.
    Sedvall GC, Wode-Helgodt B.
    Arch Gen Psychiatry; 1980 Oct 30; 37(10):1113-6. PubMed ID: 6158928
    [Abstract] [Full Text] [Related]

  • 9. Monoamine metabolite levels in cerebrospinal fluid and brain atrophy in lobotomized schizophrenic patients.
    Rimón R, Roos BE, Kampman R, Hyyppä S, Ranta P, Myllylä V.
    Ann Clin Res; 1979 Feb 30; 11(1):25-9. PubMed ID: 453776
    [Abstract] [Full Text] [Related]

  • 10. Reduction of MOPEG levels in cerebrospinal fluid of psychotic women after electroconvulsive treatment.
    Härnryd C, Bjerkenstedt L, Grimm VE, Sedvall G.
    Psychopharmacology (Berl); 1979 Aug 08; 64(2):131-4. PubMed ID: 115032
    [Abstract] [Full Text] [Related]

  • 11. Intercorrelations among monoamine metabolite concentrations in human lumbar CSF are not due to a shared acid transport system.
    Jibson M, Faull KF, Csernansky JG.
    Biol Psychiatry; 1990 Oct 01; 28(7):595-602. PubMed ID: 1699614
    [Abstract] [Full Text] [Related]

  • 12. CSF monoamine metabolites in schizophrenic patients.
    Gattaz WF, Waldmeier P, Beckmann H.
    Acta Psychiatr Scand; 1982 Nov 01; 66(5):350-60. PubMed ID: 6184954
    [Abstract] [Full Text] [Related]

  • 13. Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls.
    Engström G, Alling C, Blennow K, Regnéll G, Träskman-Bendz L.
    Eur Neuropsychopharmacol; 1999 Sep 01; 9(5):399-405. PubMed ID: 10523046
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers.
    De Bellis MD, Geracioti TD, Altemus M, Kling MA.
    Biol Psychiatry; 1999 Sep 01; 33(8-9):636-41. PubMed ID: 7687151
    [Abstract] [Full Text] [Related]

  • 17. Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia.
    Pickar D, Breier A, Hsiao JK, Doran AR, Wolkowitz OM, Pato CN, Konicki PE, Potter WZ.
    Arch Gen Psychiatry; 1990 Jul 01; 47(7):641-8. PubMed ID: 1694425
    [Abstract] [Full Text] [Related]

  • 18. Brain ventricular size and CSF monoamine metabolites in an adolescent inpatient population.
    Jennings WS, Schulz SC, Narasimhachari N, Hamer RM, Friedel RO.
    Psychiatry Res; 1985 Oct 01; 16(2):87-94. PubMed ID: 2415997
    [Abstract] [Full Text] [Related]

  • 19. Neuropsychological test performance and CSF levels of monoamine metabolites in healthy volunteers and patients with Alzheimer's dementia.
    Nybäck H, Nyman H, Schalling D.
    Acta Psychiatr Scand; 1987 Dec 01; 76(6):648-56. PubMed ID: 2450445
    [Abstract] [Full Text] [Related]

  • 20. Cerebrospinal fluid monoamine metabolite concentrations in depressive disorder: A meta-analysis of historic evidence.
    Ogawa S, Tsuchimine S, Kunugi H.
    J Psychiatr Res; 2018 Oct 01; 105():137-146. PubMed ID: 30219563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.